EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Low Expression of NQO1 Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Treated with TAC Regimen

J Grim, P Jandík, I Slánská, E Doležalová-Brčáková, L Fuksa, A Ryška, J Knížek, J Petera, S Mičuda, H Hornychová

Folia Biologica · 2012 · 58 (5) · 185-192

DOI: 10.14712/fb2012058050185 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Folia Biologica, online erschienen am 14.08.2024. Verfasst von J Grim und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology and Radiotherapy, Charles University in Prague, Faculty of Medicine and University Teaching Hospital in Hradec Králové, Czech …. Hauptthemen laut MEDLINE: Neoadjuvant Therapy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerstvo Zdravotnictví Ceské Republiky.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this study was to evaluate preoperative tumour expression of NAD(P)H:quinone oxidoreductase 1 (NQO1) along with other biological markers as potential predictors of pathological complete response (pCR) to neoadjuvant docetaxel, doxorubicin, and cyclophosphamide-containing (TAC) chemotherapy in patients with primary breast cancer. Sixty-one patients who received neoadjuvant chemotherapy (NCT) with TAC regimen were enrolled in this prospective study. The preand postNCT expression of oestrogen receptor (ER), progesterone receptor (PR), epidermal growth factor receptor 1 and 2 (EGFR and HER2), NQO1, Ki-67 proliferation index, multidrug resistance protein 1 (MDR1), p53 and BCL2 were evaluated by immunohistochemistry. The pCR was reached in 14 patients (23 % of the study group). Multivariate analysis demonstrated that patients with ER-, PR-, NQO1negative, and Ki‐67‐positive tumours had a significantly higher chance to achieve pCR. Within the biological subtypes, the highest pCR rate (50 %) was seen in triple-negative (i.e. ER-, PR-, HER2-) tumours. Post-operative evaluation showed that in comparison to pre-operative tissue samples, NQO1 expression was significantly increased, while Ki‐67 and HER2 decreased, in the residual tissue after NCT. In conclusion, the present data suggests that NQO1 expression may be a novel diagnostic biomarker for the prediction of positive response to NCT in patients with breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoadjuvant TherapyAntigens, NeoplasmAntineoplastic Combined Chemotherapy ProtocolsBreast NeoplasmsFemaleHumansImmunohistochemistryNAD(P)H Dehydrogenase (Quinone)Treatment Outcome

Substanzen

Antigens, NeoplasmNAD(P)H Dehydrogenase (Quinone)NQO1 protein, human

Autor:innen und Institutionen

  • Department of Oncology and Radiotherapy, Charles University in Prague, Faculty of Medicine and University Teaching Hospital in Hradec Králové, Czech Republic. grimj@lfhk.cuni.cz

Förderung

  • Ministerstvo Zdravotnictví Ceské Republiky

Zitieren

APA

Grim, J., Jandík, P., Slánská, I., Doležalová-Brčáková, E., Fuksa, L., Ryška, A., Knížek, J., Petera, J., Mičuda, S., & Hornychová, H. (2012). Low Expression of NQO1 Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Treated with TAC Regimen. Folia Biologica, 58(5), 185-192. https://doi.org/10.14712/fb2012058050185

Vancouver

Grim J, Jandík P, Slánská I, Doležalová-Brčáková E, Fuksa L, Ryška A, et al. Low Expression of NQO1 Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Treated with TAC Regimen. Folia Biologica. 2012;58(5):185-192. doi:10.14712/fb2012058050185

BibTeX
@article{Grim2012,
  author = {Grim, J and Jandík, P and Slánská, I and Doležalová-Brčáková, E and Fuksa, L and Ryška, A and Knížek, J and Petera, J and Mičuda, S and Hornychová, H},
  title = {Low Expression of NQO1 Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Treated with TAC Regimen},
  journal = {Folia Biologica},
  year = {2012},
  volume = {58},
  number = {5},
  pages = {185--192},
  doi = {10.14712/fb2012058050185}
}
Kostenlos starten →